NEWS: Selected from Google Alert – multiple sclerosis

Sanofi: MS drug Lemtrada has positive trial result
MarketWatch
FR) said Monday the results of a late-stage trial of multiple sclerosis drug Lemtrada were positive. The two-year study compared the experimental therapy, also known as alemtuzumab, against Merck KGaA’s MS medicine Rebif in 581 patients with …
See all stories on this topic »

Glycominds receives MS blood test approval in 3 more US states
Globes
Blood sugar analysis company Glycominds Ltd. (TASE: GLCM) has obtained marketing approval of its multiple sclerosis blood test from three more state regulatory authorities – Pennsylvania, Maryland, and Rhode Island – bringing the total number of …
See all stories on this topic »